Malignant Hypertension: An Inaugural Presentation With Atypical Pres

Authors

  • Francisco Guimarães Médico Interno de Formação Específica em Medicina Interna
  • Nataliya Polishchuk Médico Especialista em Medicina Interna
  • Luísa Fraga Fontes Médico Especialista em Medicina Interna
  • Inês Ladeira Figueiredo Médico Especialista em Medicina Interna
  • Cláudia Almeida Martins Médico Interno de Formação Específica Medicina Geral e Familiar

DOI:

https://doi.org/10.58043/rphrc.138

Keywords:

Hypertension, Atypical PRES, Hypertensive emergency

Abstract

Neurological alterations in an inaugural hypertension presentation are not uncommon, being one of the most important causes of morbidity and mortality, compromising 0.5% of all cases, and 35.9% of all hypertensive cases admitted to an emergency room1, making them of paramount importance to be investigated, controlled and post haste terminated in order to prevent recurrences. Such events can be associated with neurological symptoms, of those headaches being the most common, of a permanent intensity, sometimes even responsible for awaking the patient during their sleep, and in a more emergent presentation can be accompanied with loss of vision, hemiparesis and loss of consciousness, of whom require the quickest systematic and aggressive interventions to prevent these temporary symptoms to become permanent ones. This clinical case is an example of how, with critical thinking and the right approach we can reverse the course of an emergency towards normality, not forgetting the follow up to prevent the reoccurrence of hypertensive flares with the right medication and investigation of possible secondary causes that might’ve been undiagnosed before.

Downloads

Download data is not yet available.

References

https://doi.org/10.1161/JAHA.122.029355

https://www.revportcardiol.org/pt-sociodemographic-disparities-in-hypertension-prevalence-articulo-S0870255119304986

https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1

http://hdl.handle.net/10400.18/7527

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Feb 22;334(8):494-500. doi: 10.1056/ NEJM199602223340803. PMID: 8559202.

Anderson Redmond-Craig , Patel Vishal , Sheikh-Bahaei Nasim , Liu Chia Shang J. , Rajamohan Anandh G. , Shiroishi Mark S. , Kim Paul E. , Go John L. , Lerner Alexander , Acharya Jay, Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging, Frontiers in Neurology, volume 11, 2020, https://www.frontiersin.org/journals/ neurology/articles/10.3389/fneur.2020.00463, DOI=10.3389/fneur.2020.00463, ISSN=1664-2295

Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, et al. Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS ONE. (2012) 7:e44534. doi: 10.1371/journal.pone.0044534

Chen Z, Shen GQ, Lerner A, Gao B. Immune system activation in the pathogenesis of posterior reversible encephalopathy syndrome. Brain Res Bull. (2017) 131:93–9. doi: 10.1016/j. brainresbull.2017.03.012

Hinduja Archana, Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome, Frontiers in Neurology, Vol 11, 2020, https://www.frontiersin.org/journals/ neurology/articles/10.3389/fneur.2020.00071, DOI=10.3389/fneur.2020.00071, ISSN=1664-2295

Hinduja Archana, Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome, Frontiers in Neurology, Vol 11, 2020, https://www.frontiersin.org/journals/ neurology/articles/10.3389/fneur.2020.00071, DOI=10.3389/fneur.2020.00071, ISSN=1664-2295

Published

2024-10-18

How to Cite

1.
Guimarães F, Polishchuk N, Fraga Fontes L, Ladeira Figueiredo I, Almeida Martins C. Malignant Hypertension: An Inaugural Presentation With Atypical Pres. RH [Internet]. 2024 Oct. 18 [cited 2024 Oct. 21];(103):32-6. Available from: https://revistahipertensao.pt/index.php/rh/article/view/138

Issue

Section

Caso Clínico